Tuning Into Radiotherapeutics: Considerations for Oncology Trials



  • 3PM London / 10AM New York
  • Free

Why attend?


Select a speaker to learn more

Ashley Herrick, Ph.D.
Executive Director, Oncology Strategy, Premier Research

Dr. Ashley Herrick provides strategic planning, coordination, knowledge, and expertise for oncology projects. She has more than 13 years of experience in oncology clinical trial oversight and drug development. She has experience with all phases of clinical trials but has a keen interest and deep knowledge of early phase and first-in-man studies. She has led numerous global clinical trials and has experience with strategic management, study oversight, study start-up, efficient enrolment, and study close-out/CSR development.

Next speaker
Rupa Doshi, Ph.D.
Vice President, Oncology Strategy, Premier Research

With more than 23 years in the industry, Dr. Doshi is an experienced professional with demonstrated leadership skills in clinical operations, global project/program management, customer management and strategy development. Her experience spans the clinical development spectrum from pre-IND to NDA and she has also led global teams in the execution of full-service complex clinical trials across all phases.

Next speaker